Reading Time: 2 minutesIntroduction to Tamoxifen and Its Role in Male Breast Cancer Tamoxifen, a selective estrogen receptor modulator (SERM), has been a cornerstone in the treatment of hormone receptor-positive breast cancer. While primarily used in women, it is also prescribed for men with breast cancer, a condition that, although rare, affects approximately 2,000 American men annually. Tamoxifen works by blocking the effects of estrogen in breast tissue, thereby inhibiting the growth of cancer cells. However, its use can be associated with side effects such as hot flashes, mood swings, and an increased risk of blood clots, prompting the scientific community to seek … Continue reading →